10:39 AM EST, 11/03/2025 (MT Newswires) -- Bristol-Myers Squibb ( BMY ) on Monday launched cash tender offers for outstanding notes in two pools, with a combined maximum purchase amount of $7 billion.

The company is seeking to buy up to $4 billion of Pool 1 notes and up to $3 billion of Pool 2 notes, focusing on shorter- and longer-term maturities, respectively.

The early tender deadline is Nov. 17, 2025, with the offers scheduled to close on Dec. 3, 2025, unless extended.

Bristol Myers said the offers are contingent upon a new debt issuance by its BMS Ireland Capital Funding subsidiary, which along with about $3 billion of cash on hand, will fund the buybacks.

Price: 45.93, Change: -0.15, Percent Change: -0.31